Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics

Area of Science:

• Biochemistry
• Genetics
• Nutritional Science

Background:

• Cardiovascular disease (CVD) results from genetic and environmental factors, with many identified genes not linked to conventional risk factors.
• Gene-diet interactions, particularly with fats, complicate CVD's genetic basis.
• Polyunsaturated fatty acids (PUFAs), omega-3 and omega-6, play roles in inflammation and have been linked to reduced CVD risk.

Purpose of the Study:

• To review the metabolism of omega-3 and omega-6 PUFAs.
• To evaluate genetic and nutrigenetic evidence linking 5-lipoxygenase (5-LO) pathway genes to CVD.
• To discuss future research on gene-diet interactions in CVD.

Main Methods:

• Biochemical review of PUFA metabolism.
• Genetic and nutrigenetic evidence evaluation for 5-LO pathway genes in CVD.
• Literature synthesis on gene-diet interactions and CVD traits.

Main Results:

• Essential fatty acids (linoleic, alpha-linolenic) convert to long-chain PUFAs (arachidonic acid, EPA/DHA).
• Long-chain PUFAs are metabolized via cyclooxygenase and lipoxygenase pathways.
• The 5-lipoxygenase (5-LO)/leukotriene (LT) pathway shows biochemical and genetic links to CVD, especially with dietary arachidonic acid and EPA/DHA.

Conclusions:

• The 5-LO pathway is a significant area for investigating genetic and dietary influences on CVD.
• Further research into gene-diet interactions involving PUFAs is crucial for understanding and preventing CVD.
• Identifying specific gene-dietary interactions can lead to targeted interventions for cardiovascular health.